Virginia Tech Center for Drug Discovery News
VT research team leads $2.6 million study of brain trauma, epilepsy connection
“The unique aspect of the research is that we are specifically examining which form of injury causes epilepsy and whether there are predictive biomarkers to tell who will or will not develop epilepsy as a result of injury,” Sontheimer said. Read More
Tim Long in collaboration with a University of Virginia oncologist are testing a new gel that could relieve discomfort in cervical cancer radiation treatment.
Long and Showalter initially received funding for the project through a 4-VA grant, which is a program that sponsors certain partnerships, such as research advancements, with six state institutions, including Virginia Tech and UVA. Read More
Matt Buczynski
and researchers from the Virginia Tech School of Neuroscience are teaming with the University of California San Diego and the U.S. National Institutes of Health (NIH) to develop a drug — now in its earliest stages — that can treat certain types of chronic pain without the addictive consequences of opioids. Read More
Partnering with the
Virginia Drug Discovery Consortium
Mission Statement
- To advance the growth and stature of drug discovery and delivery research at Virginia Tech
- To assist Virginia Tech faculty members initiate basic and applied drug discovery and delivery research
- To foster a dynamic environment that promotes the recruitment of high quality faculty and students
- To vigorously pursue continuing education and economic growth through outreach activities with industry and government agencies.